Abstract

Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1

Author(s): Horace Alexis E, Akbarian-Tefagh Jessica

Issue: Sep/Oct 2013 - Volume 17, Number 5

Page(s): 388-391

Download in electronic PDF format for $75

Abstract

The question of how to disguise the taste of antiretrovirals for pediatric patients infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome is common for physicians, pharmacists, and parents/caregivers. Adherence to antiretroviral therapy is essential for living a long life and is imperative for the successful treatment of pediatric patients. The taste of these medications has been shown to affect adherence in this patient population. Parents/caregivers are not only tasked with remembering refills, dosages, and strengths of antiretrovirals, they have to become persuasive diplomats for the daily administration of these medications to their children. Provided in this first part of a two-part article is background information on this topic and a discussion on palatability concerns.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2013 Pg. 446-450	Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2 Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Sep/Oct 2013 Pg. 388-391	Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1 Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Sep/Oct 2000 Pg. 334	Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome Author(s): Mathews Elizabeth
Jan/Feb 2003 Pg. 48-50	Featured Excipient: Flavor Enhancing Agents Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 90-92	Flavors and Flavoring Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 396-400	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 6-8	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
Mar/Apr 1997 Pg. 84-86	Compounding for the Pediatric Patient Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 220-225	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2001 Pg. 9-12	Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Author(s): Schotik Debora
Nov/Dec 2022 Pg. 446-466	Compounding with Biotechnology Products, Part 2: Product-specific Considerations Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 13-16	Flavoring: Compounding a Treat Author(s): Kloesel Lawson G
Nov/Dec 2008 Pg. 482-487	Compounding Challenges for Immunocompromised Patients Author(s): McElhiney Linda F
May/Jun 2016 Pg. 247-249	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Author(s): Nahata Milap C
Sep/Oct 2016 Pg. 367-374	Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Author(s): Kochanowska-Karamyan Anna J
Jul/Aug 2019 Pg. 324-331	Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients Author(s): de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro
May/Jun 2019 Pg. 192-199	Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Author(s): Riepl Mike
Jul/Aug 2010 Pg. 328-331	Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Author(s): Okeke Claudia C, Allen Loyd V Jr
Jul/Aug 1999 Pg. 274-276	Extemporaneous Formulations in Pediatric Patients Author(s): Nahata Milap C
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D